Short-term Use of Ventricular Assist Device in a Patient With Restrictive Cardiomyopathy: A Case Report

F Rodríguez-Mora; E M Cantero-Pérez; C A Rojas-Bermúdez; J M Borrego-Domínguez; Á Herruzo-Avilés; R Hinojosa-Pérez; A Adsuar-Gómez

doi:10.1016/j.transproceed.2017.12.035

Short-term Use of Ventricular Assist Device in a Patient With Restrictive Cardiomyopathy: A Case Report

Transplant Proc. 2018 Mar;50(2):653-654. doi: 10.1016/j.transproceed.2017.12.035.

Authors

F Rodríguez-Mora¹, E M Cantero-Pérez², C A Rojas-Bermúdez¹, J M Borrego-Domínguez¹, Á Herruzo-Avilés³, R Hinojosa-Pérez³, A Adsuar-Gómez⁴

Affiliations

¹ Cardiac Surgery Department, Virgen del Rocío University Hospital, Seville, Spain.
² Cardiology Department, Virgen del Rocío University Hospital, Seville, Spain.
³ Intensive Care Unit, Virgen del Rocío University Hospital, Seville, Spain.
⁴ Cardiac Surgery Department, Virgen del Rocío University Hospital, Seville, Spain. Electronic address: alejandro.adsuar@gmail.com.

PMID: 29579879
DOI: 10.1016/j.transproceed.2017.12.035

Abstract

The CentriMag (Levitronix LLC, Waltham, MA, USA) ventricular assist device is a centrifugal pump designed for short-term support in patients with cardiogenic shock. In patients with restrictive physiology, there is some concern about the use of these devices due a very small ventricular cavity. We review the evolution of a 32-year-old woman with restrictive cardiomyopathy, moderate pulmonary hypertension, and severe biventricular systo-diastolic dysfunction in whom a biventricular Centrimag device was implanted due to a progressive clinical worsening.

Publication types

Case Reports

MeSH terms

Adult
Cardiomyopathy, Restrictive / therapy*
Female
Heart-Assist Devices*
Humans